• Home
  • Study Details
Coming Soon

PROMOTE: ImPact of the MicRobiome and ImmunOtherapy on the TreatMent and ProgressiOn of EndomeTrial CancEr

The purpose of this study is to learn how microbes in the uterus and gut (bacteria, viruses, fungi) and your own innate immune system (the first line of defense of the body) impacts how well certain treatments work for endometrial cancer. This is a hybrid decentralized study where some if not all assessments may be performed close to your home.

Age & Gender

  • 18 years ~ 99 years
  • Female

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Olivia Lara
LCCC - Clinical Trials

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Uterine (endometrial))

IRB Number

25-0920

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research